Simufilam success already priced in to Cassava, and CONMED a buy in today's analyst action

78
7
Favorite

Simufilam success already priced in to Cassava, and CONMED a buy in today's analyst action

seekingalpha2021-07-16

Positive simufilam data may already be priced into Cassava With the Alzheimer's Association International Conference less than two weeks away, Cantor Fitzgerald is downgrading shares of Alzheimer's ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（7）

Ila
·2021-07-16
Like and comment pls
Reply
Like
Report
abp
·2021-07-16
Pls like and comment
Reply
2
Report
Fold Replies
- Ila:
  Nice
  2021-07-16
  Reply
  Report
BabySim
·2021-07-16
Comment
Reply
3
Report
Fold Replies
- Kelvin17:
  Like and comment pls
  2021-07-16
  Reply
  Report
- abp:
  Pls like and comment
  2021-07-16
  Reply
  Report
- DarrylWong:
  like and comment pls
  2021-07-16
  Reply
  Report
KopiLim
·2021-07-16
For like and comment
Reply
9
Report
Fold Replies
- abp:
  Done
  2021-07-16
  Reply
  Report
- Bry8950:
  Ok
  2021-07-16
  Reply
  Report
- LiL60:
  Done
  2021-07-16
  Reply
  Report
sentosa
·2021-07-16
Our investors can get any benefit
Reply
6
Report
Fold Replies
- BabySim:
  Ok
  2021-07-16
  Reply
  Report
Delvin
·2021-07-16
Ok
Reply
1
Report
Fold Replies
- Xuehao:
  like back pls
  2021-07-16
  Reply
  Report
poworb
·2021-07-16
Gd
Reply
3
Report
Fold Replies
- mmcjb92:
  O
  2021-07-16
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1190597896?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-07-16 17:18","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1190597896","market":"us","top_or_hot":-1,"title":"Simufilam success already priced in to Cassava, and CONMED a buy in today's analyst action","media":"seekingalpha","content":"<div>\n<p>Positive simufilam data may already be priced into Cassava\n\nWith the Alzheimer's Association International Conference less than two weeks away, Cantor Fitzgerald is downgrading shares of Alzheimer's ...</p>\n\n<a href=\"https://seekingalpha.com/news/3715468-simufilam-success-already-priced-in-to-cassava-and-more-in-todays-analyst-action\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Simufilam success already priced in to Cassava, and CONMED a buy in today's analyst action</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSimufilam success already priced in to Cassava, and CONMED a buy in today's analyst action\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 17:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3715468-simufilam-success-already-priced-in-to-cassava-and-more-in-todays-analyst-action><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Positive simufilam data may already be priced into Cassava\n\nWith the Alzheimer's Association International Conference less than two weeks away, Cantor Fitzgerald is downgrading shares of Alzheimer's ...</p>\n\n<a href=\"https://seekingalpha.com/news/3715468-simufilam-success-already-priced-in-to-cassava-and-more-in-todays-analyst-action\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SAVA","symbol_name":"Cassava Sciences Inc","start_time":0,"source_url":"https://seekingalpha.com/news/3715468-simufilam-success-already-priced-in-to-cassava-and-more-in-todays-analyst-action","article_id":"1190597896","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190597896","pubTimestamp":1626427128,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Positive simufilam data may already be priced into Cassava\n\nWith the Alzheimer's Association Interna","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"SAVA":"Cassava Sciences Inc","ARGX":"Argenx SE","BIIB":"渤健公司","CNMD":"CONMED Corporation"},"translate_title":"Simufilam success已经对木薯进行了定价，并在今天的分析师行动中获得了买入","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARGX":0.9,"BIIB":0.9,"CNMD":0.9,"SAVA":0.9},"content_text":"Positive simufilam data may already be priced into Cassava\n\nWith the Alzheimer's Association International Conference less than two weeks away, Cantor Fitzgerald is downgrading shares of Alzheimer's player Cassava Sciences (SAVA) from overweight to neutral, but is raising the price target to $100 (3% upside).\nAnalyst Charles Duncan finds it hard for shares to trade much higher, given they are up 1400% year-to-date.\nDuncan expects that data from a 9-month interim analysis of simufilam to be incrementally positive as it will likely just reinforce the drug's potential. However, if significant improvement is shown in the updated analysis, the stock could trade higher, he adds.\nFollowing the approvaland pricing of Biogen's (BIIB) Aduhelm (aducanumab) at $56K per year, Duncan is also raising his price estimate for simufilam to $52K annually.\n\nCONMED initiated as a buy at UBS\n\nUBS has initiated shares of medical technology and device company CONMED (CNMD) with a buy rating and a $160 price target (~21% upside).\nThe firm says the company has benefitted from a focused management team, the acquisitions of AirSeal and Buffalo Filter, and differentiated products.\n\"Lab survey data suggests favorable Q2 results risk reward as well as more bullish 2H and 2022 outlook can act as catalysts for the stock,\" UBS says.\n\nargenx reiterated as buy at Wainwright on R&D update\n\nH.C. Wainwright is maintaining its buy rating on shares of argenx SE (ARGX) following the company announcement of highlights for its upcoming R&D day.\nAnalyst Douglas Tsao says he is excited by additional indications for efgartigimod in the neuromuscular area, as well as one possibly in bullous or mucous membrane pemphigoid.\nTsao believes that this latter rare disease indication alone could result in $200M-$300M in revenue.\nEfgartigimod is currently under development in four indications and has aPDUFA date of December 17, 2021for generalized myasthenia gravis.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":170235510,"gmtCreate":1626434542430,"gmtModify":1703760086764,"author":{"id":"4087269899936440","authorId":"4087269899936440","name":"Ila","avatar":"https://static.tigerbbs.com/32af1e4c2b8f858b50b2e874760ab13d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4087269899936440","idStr":"4087269899936440"},"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/170235510","repostId":1190597896,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":170299183,"gmtCreate":1626433080142,"gmtModify":1703760062785,"author":{"id":"3581979721991802","authorId":"3581979721991802","name":"abp","avatar":"https://static.tigerbbs.com/f0c0424f61209387c56148e921c507f1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581979721991802","idStr":"3581979721991802"},"htmlText":"Pls like and comment","listText":"Pls like and comment","text":"Pls like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/170299183","repostId":1190597896,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5239340,"gmtCreate":1626434574655,"gmtModify":1663231057628,"authorId":4087269899936440,"author":{"id":4087269899936440,"idStr":"4087269899936440","authorId":4087269899936440,"name":"Ila","avatar":"https://static.tigerbbs.com/32af1e4c2b8f858b50b2e874760ab13d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170299183,"type":1,"supId":0,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"}],"langContent":"EN"},{"id":170646891,"gmtCreate":1626430217013,"gmtModify":1703760022621,"author":{"id":"3579673211261157","authorId":"3579673211261157","name":"BabySim","avatar":"https://static.tigerbbs.com/5c6f0cd54fab9f24929e66e54e08e3aa","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"3579673211261157","idStr":"3579673211261157"},"htmlText":"Comment&nbsp;","listText":"Comment&nbsp;","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/170646891","repostId":1190597896,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5239122,"gmtCreate":1626432785264,"gmtModify":1663231059047,"authorId":3581651271010576,"author":{"id":3581651271010576,"idStr":"3581651271010576","authorId":3581651271010576,"name":"Kelvin17","avatar":"https://static.tigerbbs.com/5ad690dc5b75f93cb92a855c9ee59cee","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170646891,"type":1,"supId":0,"prevId":0,"content":"Like and comment pls","text":"Like and comment pls","html":"Like and comment pls"},{"id":5239152,"gmtCreate":1626433091104,"gmtModify":1663231057731,"authorId":3581979721991802,"author":{"id":3581979721991802,"idStr":"3581979721991802","authorId":3581979721991802,"name":"abp","avatar":"https://static.tigerbbs.com/f0c0424f61209387c56148e921c507f1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170646891,"type":1,"supId":0,"prevId":0,"content":"Pls like and comment","text":"Pls like and comment","html":"Pls like and comment"},{"id":5238934,"gmtCreate":1626430428346,"gmtModify":1663231054747,"authorId":3580190462625568,"author":{"id":3580190462625568,"idStr":"3580190462625568","authorId":3580190462625568,"name":"DarrylWong","avatar":"https://static.tigerbbs.com/8e4b82d595be883bcd8e099845c3f407","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170646891,"type":1,"supId":0,"prevId":0,"content":"like and comment pls","text":"like and comment pls","html":"like and comment pls"}],"langContent":"EN"},{"id":170623915,"gmtCreate":1626427967837,"gmtModify":1703759989623,"author":{"id":"3562886608344748","authorId":"3562886608344748","name":"KopiLim","avatar":"https://static.tigerbbs.com/04fcef53a2e715c173a40fafa14a7fe6","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3562886608344748","idStr":"3562886608344748"},"htmlText":"For like and comment&nbsp;","listText":"For like and comment&nbsp;","text":"For like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/170623915","repostId":1190597896,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5239153,"gmtCreate":1626433113808,"gmtModify":1663231057544,"authorId":3581979721991802,"author":{"id":3581979721991802,"idStr":"3581979721991802","authorId":3581979721991802,"name":"abp","avatar":"https://static.tigerbbs.com/f0c0424f61209387c56148e921c507f1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170623915,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":5238854,"gmtCreate":1626429362935,"gmtModify":1663231055639,"authorId":3579932836090058,"author":{"id":3579932836090058,"idStr":"3579932836090058","authorId":3579932836090058,"name":"Bry8950","avatar":"https://static.tigerbbs.com/a9521192817425a7661a2344c9ae4687","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170623915,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":5238755,"gmtCreate":1626428314411,"gmtModify":1663231054844,"authorId":3583410085434046,"author":{"id":3583410085434046,"idStr":"3583410085434046","authorId":3583410085434046,"name":"LiL60","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170623915,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"}],"langContent":"EN"},{"id":170629071,"gmtCreate":1626427884793,"gmtModify":1703759988300,"author":{"id":"3586496569555403","authorId":"3586496569555403","name":"sentosa","avatar":"https://static.tigerbbs.com/38bcd9864ecb6b17ff9516da7db00132","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586496569555403","idStr":"3586496569555403"},"htmlText":"Our investors can get any benefit","listText":"Our investors can get any benefit","text":"Our investors can get any benefit","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/170629071","repostId":1190597896,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5238922,"gmtCreate":1626430212689,"gmtModify":1663231057539,"authorId":3579673211261157,"author":{"id":3579673211261157,"idStr":"3579673211261157","authorId":3579673211261157,"name":"BabySim","avatar":"https://static.tigerbbs.com/5c6f0cd54fab9f24929e66e54e08e3aa","vip":1,"currentWearingBadge":{"badgeId":"4e86300037264823b9bb00ff44fc0f19-2","templateUuid":"4e86300037264823b9bb00ff44fc0f19","name":"Live trading challenger","description":"for 4 months ","bigImgUrl":"https://community-static.tradeup.com/news/555a9001c6de2ba066c0850c80b6475a","smallImgUrl":"https://community-static.tradeup.com/news/acd8d1536c6533b9c274771f100401c4","grayImgUrl":"https://community-static.tradeup.com/news/1c254e1fa3d75a472d0f55ebb1dd1ff4","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.03","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":5600},"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170629071,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":170662298,"gmtCreate":1626427555014,"gmtModify":1703759981375,"author":{"id":"3575200533809324","authorId":"3575200533809324","name":"Delvin","avatar":"https://static.tigerbbs.com/93738020b8156486e54265bfacf43f4b","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"3575200533809324","idStr":"3575200533809324"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/170662298","repostId":1190597896,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5238683,"gmtCreate":1626427689814,"gmtModify":1663231057247,"authorId":3583491361400942,"author":{"id":3583491361400942,"idStr":"3583491361400942","authorId":3583491361400942,"name":"Xuehao","avatar":"https://static.tigerbbs.com/68f8f0968bdff0787e4a34cf6caf8f84","vip":1,"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170662298,"type":1,"supId":0,"prevId":0,"content":"like back <u>pls</u>","text":"like back <u>pls</u>","html":"like back <u>pls</u>"}],"langContent":"EN"},{"id":170662192,"gmtCreate":1626427545716,"gmtModify":1703759980551,"author":{"id":"3585789495202228","authorId":"3585789495202228","name":"poworb","avatar":"https://static.tigerbbs.com/a0c7f322470251fc4ca32b11d191c166","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3585789495202228","idStr":"3585789495202228"},"htmlText":"Gd","listText":"Gd","text":"Gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/170662192","repostId":1190597896,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5238692,"gmtCreate":1626427784893,"gmtModify":1663231057631,"authorId":4087294932864220,"author":{"id":4087294932864220,"idStr":"4087294932864220","authorId":4087294932864220,"name":"mmcjb92","avatar":"https://static.tigerbbs.com/cb0c911ee6f94cd0092cc258580fd6fa","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170662192,"type":1,"supId":0,"prevId":0,"content":"<u>O</u>","text":"<u>O</u>","html":"<u>O</u>"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":78,"commentSize":7,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}